Mo. Code Regs. tit. 19 § 30-1.002

Current through Register Vol. 49, No. 9, May 1, 2024

Section 19 CSR 30-1.002 - Schedules of Controlled Substances

PURPOSE: This amendment updates the Schedules of Controlled Substances to be consistent with 21 CFR Part 1308 .

PUBLISHER'S NOTE: The secretary of state has determined that the publication of the entire text of the material which is incorporated by reference as a portion of this rule would be unduly cumbersome or expensive. This material as incorporated by reference in this rule shall be maintained by the agency at its headquarters and shall be made available to the public for inspection and copying at no more than the actual cost of reproduction. This note applies only to the reference material. The entire text of the rule is printed here.

(1) Schedules of Controlled Substances.

(A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

1. Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl)-N-phenylacetamide)	9815
B. Acetylmethadol	9601
C. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)	9821
D. N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: acryl fentanyl, acryloylfentanyl)	9811
E. AH-7921(3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide)	9551
F. Allylprodine	9602
G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alpha-acetylmethadol levothadyl acetate or LAAM)	9603
H. Alphameprodine	9604
I. Alphamethadol	9605
J. Alpha-methylfentanyl (N-1-(alphamethyl-beta-phenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4 ((N-propanilido) piperidine)	9814
K. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N-phenylpropanamide)	9832
L. Benzethidine	9606
M. Betacetylmethadol	9607
N. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2-phenethyl)-4-piperidinyl)-N-phenylpropanamide)	9830
O. Beta-hydroxy-3-methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl)-N-phenylpropanamide)	9831
P. N-[1-[2-hydroxy-2-(thiophen-2-yl) ethylpiperidin-4-yl]-N-phenylpropionamide (other names: beta-hydroxythiofentanyl)	9836
Q. Betameprodine	9608
R. Betamethadol	9609
S. beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl) propionamide (Other name: [BETA]-methyl fentanyl)	9856
T. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (other names: [BETA]'-phenyl fentanyl; 3-phenylpropanoyl Fentanyl)	9842
U. Betaprodine	9611
V. Brorphine (1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)	9098
W. Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)	9822
X. Clonitazene	9612
Y. Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)	9844
Z. N-(1-phenethylpiperidin-4-yl)-N-Phenylcyclopentanecarboxamide (other name: cyclopentyl fentanyl)	9847
AA. Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)	9845
BB. Dextromoramide	9613
CC. Diampromide	9615
DD. Diethylthiambutene	9616
EE. Difenoxin	9168
FF. Dimenoxadol	9617
GG. Dimepheptanol	9618
HH. Dimethylthiambutene	9619
II. Dioxaphetyl butyrate	9621
JJ. Dipipanone	9622
KK. Ethylmethylthiambutene	9623
LL. Etonitazene	9624
MM. Etoxeridine	9625
NN. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate)	9851
OO. N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl)	9824
PP. 2'-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl) piperidin-4-yl)-N-(2-fluorophenyl) propionamide (other names: 2'-fluoro 2-fluorofentanyl)	9855
QQ. N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (other names: furanyl fentanyl)	9834
RR. Furethidine	9626
SS. Hydroxypethidine	9627
TT. N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (other name: isobutyryl fentanyl)	9827
UU. Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl) ethan-1-amine)	9614
VV. Ketobemidone	9628
WW. Levomoramide	9629
XX. Levophenacylmorphan	9631
YY. Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide	9825
ZZ. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N-phenylacetamide)	9819
AAA. 3-Methylfentanyl (N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylproanamide), its optical and geometric isomers, salts, and salts of isomers	9813
BBB. 3-Methylthiofentanyl (N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N-phenylpropanamide)	9833
CCC. Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)	9757
DDD. Morpheridine	9632
EEE. MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)	9661
FFF. MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl) piperazine)	(9560)
GGG. Noracymethadol	9633
HHH. Norlevorphanol	9634
III. Normethadone	9635
JJJ. Norpipanone	9636
KKK. N-(2-fluorophenyl)-2-methoxy-N-(1 phenethylpiperidin-4-yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: ocfentanil)	9838
LLL. ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) acrylamide)	9852
MMM. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) butyramide (other name: 2-fluorobutyryl fentanyl)	9846
NNN. ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl)	9816
OOO. ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)	9853
PPP. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide (other name: 2-methyl acetylfentanyl)	9848
QQQ. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide (other name: 2-methyl methoxyacetyl fentanyl)	9820
RRR. N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (other name: parachloroisobutyryl fentanyl)	9826
SSS. para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)	9823
TTT. para-Fluorofentanyl(N-(4-fluorophenyl)-N-(1-(2-phenethyl)-4-piperidinyl) propanamide	9812
UUU. para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)	9854
VVV. para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl) butyramide)	9837
WWW. para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl) propionamide (other name: 4-methylfentanyl)	9817
XXX. PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine)	9663
YYY. Phenadoxone	9637
ZZZ. Phenampromide	9638
AAAA. Phenomorphan	9647
BBBB. Phenoperidine	9641
CCCC. Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (other name: benzoyl fentanyl)	9841
DDDD. Piritramide	9642
EEEE. Proheptazine	9643
FFFF. Properidine	9644
GGGG. Propiram	9649
HHHH. Racemoramide	9645
IIII. N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: tetrahydrofuranyl fentanyl)	9843
JJJJ. Thiofentany (N-phenyl-N-(1-(2-thienyl)ethyl-4-piperidinyl)-propanamide	9835
KKKK. Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (other names: 2-thiofuranyl fentanyl; thiophene fentanyl)	9839
LLLL. Tilidine	9750
MMMM. Trimeperidine	9646
NNNN. U-47700 (3,4-Dichloro-N-[2-(dimethylamino) cyclohexyl]-N-methylbenzamide)	9547
OOOO. N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (other name: valeryl fentanyl)	9840
PPPP. Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl) piperazin-1-yl]-1-phenylpropan-2-ol)	9873

2. Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Acetorphine	9319
B. Acetyldihydrocodeine	9051
C. Benzylmorphine	9052
D. Codeine methylbromide	9070
E. Codeine-N-Oxide	9053
F. Cyprenorphine	9054
G. Desomorphine	9055
H. Dihydromorphine	9145
I. Drotebanol	9335
J. Etorphine (except hydrochloride salt)	9056
K. Heroin	9200
L. Hydromorphinol	9301
M. Methyldesorphine	9302
N. Methyldihydromorphine	9304
O. Morphine methylbromide	9305
P. Morphine methylsulfonate	9306
Q. Morphine-N-Oxide	9307
R. Myrophine	9308
S. Nicocodeine	9309
T. Nicomorphine	9312
U. Normorphine	9313
V. Pholcodine	9314
W. Thebacon	9315

3. Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)3. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

A. Alpha-ethyltryptamine	7249
Some trade or other names: etryptamine; Monase; alpha- ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha- ET; and AET;
B. 4-bromo-2,5-dimethoxyamphetamine Some trade or other names: 4-bromo-2, 5- dimethoxy-a-methylphenethylamine; 4-bromo-2, 5-DMA;
C. 4-bromo-2,5-dimethoxyphenethylamine	7392
D. 2,5-dimethoxyamphetamine Some trade or other names: 2,5-dimethoxy-amethylphenethylamine; 2,5-DMA;	7396
E. 2,5-dimethoxy-4-ethylamphetamine Some trade or other names: DOET;	7399
F. 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)	7348
G. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)	7524
H. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)	7509
I. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)	7508
J. 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)	7521
K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)	7517
L. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)	7519
M. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)	7385
N. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)	7518
O. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)	7532
P. 4-methoxyamphetamine Some trade or other names: 4-methoxy- amethylphenethylamine; paramethoxyamphetamine; PMA;	7411
Q. 5-methoxy-3,4-methylenedioxyamphetamine	7401
R. 4-methyl-2,5-dimethoxyamphetamine Some trade and other names: 4-methyl-2, 5- dimethoxy-a- methylphenethylamine; DOM; and STP;	7395
S. 3,4-methylenedioxyamphetamine	7400
T. 3,4-methylenedioxymetham-phetamine(MDMA)	7405
U. 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethylalpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)	7404
V. N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine and N-hydroxy MDA)	7402
W. 3,4,5-trimethoxyamphetamine	7390
X. 5-MeO-DMT or 5-methoxy-N,N-dimethyltryptamine	7431
Y. Alpha-methyltryptamine	7432
Z. Bufotenine Some trade and other names: 3-(b-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine;	7433
AA. Diethyltryptamine Some trade and other names: N, N-Diethyltryptamine; DET;	7434
BB. Dimethyltryptamine Some trade or other names: DMT;	7435
CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)	7439
DD. Ibogaine Some trade and other names: 7-Ethyl- 6,6ß,7,8,9,10,12,13- octahydro-2-methoxy-6, 9-methano-5H-pyrido [1',2':1,2] azepino[5,4-b] indole; Tabernanthe iboga;	7260
EE. Lysergic acid diethylamide	7315
FF. Marihuana Some trade or other names: marijuana;	7360
GG. Mescaline	7381
HH. Parahexyl Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;	7374
II. Peyote Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts;	7415
JJ. N-ethyl-3-piperidyl benzilate	7482
KK. N-methyl-3-piperidyl benzilate	7484
LL. Psilocybin	7437
MM. Psilocyn	7438
NN. Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: (I) 1 cis or trans tetrahydrocannabinol and their optical isomers; (II) 6 cis or trans tetrahydrocannabinol and their optical isomers; (III) 3,4 cis or trans tetrahydrocannabinol and its optical isomers; and (IV) Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered;
OO. Ethylamine analog of phencyclidine Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)-ethylamine, cyclohexamine, PCE;	7455
PP. Pyrrolidine analog of phencyclidine Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;	7458
QQ. Thiophene analog of phencyclidine Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;	7470
RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine Some other names: TCPy;	7473
SS. Salvia divinorum
TT. Salvinorin A
UU. 3-Fluoromethcathinone	1233
VV. 4-Fluoromethcathinone	1238
WW. Mephedrone, or 4-methylmethcathinone	1248
XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone	7535
YY. Methylone, or 3,4-Methylenedioxymethcathinone	7540
ZZ. Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate (PB-22; QUPIC)	7222
AAA. Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)	7225
BBB. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1Hindazole-3-carboxamide (AB-FUBINACA)	7012
CCC. N-(1-amino-3, 3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)	7035
DDD. (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopro-poyl)indole)	7144
EEE. [1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR-144, XLR11, 1-(5-fluo-ropentyl)-3-(2,2,3,3-tetramethylcyclopro-poyl)indole)	7011
FFF. N-(1-adamantyl)-1-pentyl-1Hindazole-3-carboxamide (other names: APINACA, AKB48)	7048
GGG. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 251-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)	7538
HHH. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)	7537
III. 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)	7536
JJJ. 4-methyl-N-ethylcathinone (other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one)	1249
KKK. 4-methyl-alphapyrrolid-inopropiophenone, (other names: 4-MePPP; MePPP; 4-methyl-[ALPHA]-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)	7498
LLL. alphapyrrolidinopentio-phenone (other names: [ALPHA]-PVP; [ALPHA]-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one)	7545
MMM. Butylone (other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one)	7541
NNN. Pentedrone (other names: [ALPHA]-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one)	1246
OOO. Pentylone (other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one)	7542
PPP. Naphyrone (other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one)	1258
QQQ. alpha-pyrrolidinobutio-phenone (other names: [ALPHA]-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one)	7546
RRR. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (other names: AB-CHMINACA)	7031
SSS. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide (other names: AB-PINACA)	7023
TTT. [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (other names: THJ-2201)	7024
UUU. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (other names: MAB-CHMINACA; ADB-CHMINACA)	7032
VVV. methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-ADB; 5F-MDMB-PINACA)	7034
WWW. methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other names: 5F-AMB)	7033
XXX. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (other names: 5F-APINACA, 5F- AKB48)	7049
YYY. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: ADB-FUBINACA)	7010
ZZZ. methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: MDMB-CHMICA, MMB-CHMINACA)	7042
AAAA. methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other names: MDMB-FUBINACA)	7020
BBBB. methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other names: FUB-AMB, MMB- FUBINACA, AMB-FUBINACA)	(7021)
CCCC. 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) propan-1-one (ethylone)	7547
DDDD. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other names: NM2201; CBL2201)	7221
EEEE. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (other name: 5F-AB-PINACA)	7025
FFFF. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 4-CN-CUMYLBUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYLBINACA; CUMYL-4CNBINACA; SGT-78)	7089
GGGG. methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (other names: MMB-CHMICA; AMB-CHMICA)	7044
HHHH. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b] pyridine-3-carboxamide (other name: 5F-CUMYL-P7AICA)	7085
IIII. N-ethylpentylone (other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one)	7543
JJJJ. methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)	7043
KKKK. 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)	1245
LLLL. ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)	7036
MMMM. methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-Dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)	7041
NNNN. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))	7047
OOOO. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names 5F-CUMYL-PINACA; SGT-25)	7083
PPPP. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other name: FUB-144)	7014
QQQQ. N-Ethylhexedrone (other names: [ALPHA]-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)	7246
RRRR. alpha-Pyrrolidinohexanophenone (other names: [ALPHA]-PHP; [ALPHA]-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)	7544
SSSS. 4-Methyl-alpha-ethylaminopentiophenone (other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)	7245
TTTT. 4'-Methyl-alpha-pyrrolidinohexiophenone (other names: MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexa-1-one)	7446
UUUU. alpha-Pyrrolidinoheptaphenone (other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)	7548
VVVV. 4'-Chloro-alpha-pyrrolidinovalerophenone (other names: 4-chloro-[ALPHA]-PVP; 4'-chloro-[ALPHA]- pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl) pentan-1-one)	7443
WWWW. 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)	7286
XXXX. 1-(1,3-benzodioxol-5-yl)-2-9 (ethylamino)butan-1-one (other names: eutylone; bk-EBDB)	7549
YYYY. Synthetic cannabinoids: & Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(I) Any compound structurally derived from 3-(1-naphthoyl)indole or 1Hindol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:
(a) AM2201, or 1-(5-fluoropentyl)-3-(1-naphthoyl)indole	7201
(b) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole
(c) JWH-015, or 1-propyl-2-methyl-3-(1-naphthoyl)indole
(d) JWH-018, or 1-pentyl-3-(1-naphthoyl)indole	7118
(e) JWH-019, or 1-hexyl-3-(1-naphthoyl)indole	7019
(f) JWH-073, or 1-butyl-3-(1-naphthoyl)indole	7173
(g) JWH-081, or 1-pentyl-3-(4-methoxy-1-naphthoyl)indole	7081
(h) JWH-098, or 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole
(i) JWH-122, or 1-pentyl-3-(4-methyl-1-naphthoyl)indole	7122
(j) JWH-164, or 1-pentyl-3-(7-methoxy-1-naphthoyl)indole
(k) JWH-200, or 1-(2-(4-(morpholinyl)ethyl)) 3-(1-naphthoyl)indole	7200
(l) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole
(m) JWH-398, or 1-pentyl-3-(4-chloro-1-naphthoyl)indole	7398
(II) Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
(III) Any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
(IV) Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
(a) JWH-201, or 1-pentyl-3-(4-methoxyphenylacetyl)indole
(b) JWH-203, or 1-pentyl-3-(2-chloropheny- lacetyl)indole	7203
(c) JWH-250, or 1-pentyl-3-(2-methoxypheny-lacetyl)indole	6250
(d) JWH-251, or 1-pentyl-3-(2-methylphenylacetyl)indole
(e) RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxypheny-lacetyl)indole	7008
(V) Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:
(a) CP 47,497 & homologues, or 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7	7297, 7298
(VI) Any compound containing a 3- (benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
(a) AM-694, or 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole	7694
(b) RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole (SR-19 and RCS-4)	7104
(VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate;
(VIII) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;
(IX) HU-211, or Dexanabinol,(6aS,10aS)-9- (hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
(X) Dimethylheptylpyran, or DMHP.

4. Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Gamma-hydroxybutyric acid and other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate;	2010
B. Mecloqualone	2572
C. Methaqualone	2565

5. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

A. Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino] heptanoic acid)	1219
B. Aminorex Some trade or other names: aminoxaphen; 2-amino-5-phenyl-2- oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;	1585
C. N-benzylpiperazine (some other names: BZP, 1-benzylpiperzaine)	7493
D. Cathinone (Some trade or other names: 2-amino-1-phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone)	1235
E. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)	1595
F. Fenethylline	1503
G. Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)	1227
H. Methcathinone Some trade or other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;	1237
I. Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)	1478
J. 4-methoxymethcathinone
K. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)	1590
L. 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP
M. N-ethylamphetamine	1475
N. N,N-dimethylamphetamine (some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alpha-trimethylphenethylamine)	1480

6. A temporary listing of substances subject to emergency scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.	9850
(I) Fentanyl-related substance means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:
(a) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;
(b) Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;
(c) Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;
(d) Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or
(e) Replacement of the N-propionyl group by another acyl group.
B. 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Butonitazene)	9751
C. 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: Etodesnitazene; etazene)	9765
D. N, N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Flunitazene)	9756
E. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metodesnitazene)	9764
F. 2-(4-ethoxybenzyl)-5-nitro-1- (2-(pyrrolidin-1-yl)ethyl) -1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: N-pyrrolidino etonitazene; etonitazepyne)	9758
G. N, N-diethyl-2-(5-nitro-2-(4-propoxybenzyl) -1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Protonitazene)	9759
H. 4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: etizolam)	2780
I. 4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: flualprazolam)	2785
J. 6-(2-chlorophenyl)-1-methyl-8- nitro-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: clonazolam)	2786
K. 8-bromo-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: flubromazolam)	2788
L. 7-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2Hbenzo [e][1,4]diazepin-2-one, its salts, isomers, and salts of isomers (Other name: diclazepam)	2789

7. Khat, to include all parts of the plant presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts. 7032

(B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

1. Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

A. Opium and opiate; and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

(I) Raw opium	9600
(II) Opium extracts	9610
(III) Opium fluid	9620
(IV) Powdered opium	9639
(V) Granulated opium	9640
(VI) Tincture of opium	9630
(VII) Codeine	9050
(VIII) Dihydroetorphine	9334
(IX) Ethylmorphine	9190
(X) Etorphine hydrochloride	9059
(XI) Hydrocodone	9193
(XII) Hydromorphone	9150
(XIII) Metopon	9260
(XIV) Morphine	9300
(XV) Oripavine	9330
(XVI) Oxycodone	9143
(XVII) Oxymorphone	9652
(XVIII) Thebaine	9333

B. Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

C. Opium poppy and poppy straw 9650

D. Coca leaves (9040) and any salt, compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:

(I) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or

(II) Ioflupane;

E. Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy) 9670

2. Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

A. Alfentanil	9737
B. Alphaprodine	9010
C. Anileridine	9020
D. Bezitramide	9800
E. Bulk Dextropropoxyphene (Non-dosage Forms)	9273
F. Carfentanil	9743
G. Dihydrocodeine	9120
H. Diphenoxylate	9170
I. Fentanyl	9801
J. Isomethadone	9226
K. Levo-alphacetylmethadol Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM	9648
L. Levomethorphan	9210
M. Levorphanol	9220
N. Metazocine	9240
O. Methadone	9250
P. Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane	9254
Q. Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid	9802
R. Oliceridine (N-[(3-methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate)	9245
S. Pethidine (Meperidine)	9230
T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine	9232
U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate	9233
V. Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-
4-carboxylic acid	9234
W. Phenazocine	9715
X. Piminodine	9730
Y. Racemethorphan	9732
Z. Racemorphan	9733
AA. Remifentanil	9739
BB. Sufentanil	9740
CC. Tapentadol	9780
DD. Thiafentanil	9729

3. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

A. Amphetamine, its salts, optical isomers, and salts of its optical isomers	1100
B. Lisdexamfetamine, its salts, isomers, and salts of its isomers	1205
C. Methamphetamine, its salts, isomers, and salts of its isomers	1105
D. Phenmetrazine and its salts	1631
E. Methylphenidate	1724

4. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Amobarbital	2125
B. Glutethimide	2550
C. Pentobarbital	2270
D. Phencyclidine	7471
E. Secobarbital	2315

5. Hallucinogenic substances:

A. Nabilone

Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H- dibenzo(b,d) pyran-9-one.

7379

B. Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

(7365)

6. Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

A. Immediate precursor to amphetamine and methamphetamine: (I) Phenylacetone Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;	8501
B. Immediate precursors to phencyclidine (PCP):
(I) 1-phenylcyclohexylamine	7460
(II) 1-piperidinocyclo-hexanecarbonitrile (PCC)	8603
C. Immediate precursor to fentanyl:
(I) 4-anilino-N-phenethyl-4-piperidine (ANPP)	8333
(II) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)	8366

7. Any material, compound, mixture, or preparation which contains any quantity of the following alkyl nitrites:

A. Amyl nitrite;

B. Butyl nitrite.

(C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

1. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances	1405
B. Benzphetamine	1228
C. Chlorphentermine	1645
D. Clortermine	1647
E. Phendimetrazine	1615

2. Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

A. Any compound, mixture, or preparation containing-
(I) Amobarbital	2126
(II) Secobarbital	2316
(III) Pentobarbital or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;	2271
B. Any suppository dosage form containing-
(I) Amobarbital	2126
(II) Secobarbital	2316
(III) Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;	2271
C. Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof	2100
D. Chlorhexadol	2510
E. Embutramide	2020
F. Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;	2012
G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone)	7285
H. Lysergic acid	7300
I. Lysergic acid amide	7310
J. Methyprylon	2575
K. Perampanel, and its salts, isomers, and salts of isomers	2261
L. Sulfondiethylmethane	2600
M. Sulfonethylmethane	2605
N. Sulfonmethane	2610
O. Tiletamine and zolazepam or any salt thereof Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin-7(1H)-one, flupyrazapon.	7295

3. Nalorphine 9400

4. Narcotics drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

A. Not more than one and eight tenths grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium	9803
B. Not more than one and eight tenths grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts	9804
C. Not more than one and eight tenths grams (1.8gm) of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts	9807
D. Not more than three hundred milligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts	9808
E. Not more than five hundred milligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts	9809
F. Not more than fifty milligrams (50 mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts	9810

5. Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below:

A. Buprenorphine

9064

6. Anabolic steroids.

Unless specifically excepted or unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in 21 CFR 1300.01, of the August 1, 2023, Code of Federal Regulations, as published by the Office of the Federal Register, National Archives and Records Administration, 700 Pennsylvania Avenue, Washington, DC 20408, which is hereby incorporated by reference and does not include later amendments or additions, including any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters, and ethers (4000):

A. 5[ALPHA]-androstan-3,17-dione;

B. 5[ALPHA]-androstan-3,6,17-trione;

C. 1-androstenediol (3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene);

D. 1-androstenediol (3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene);

E. 4-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-4-ene);

F. 5-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-5-ene);

G. 1-androstenedione (5[ALPHA]-androst-1-en-3,17-dione);

H. 4-androstenedione (androst-4-en-3,17-dione);

I. 5-androstenedione (androst-5-en-3,17-dione);

J. bolasterone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one);

K. boldenone (17[BETA]-hydroxyandrost-1,4-diene-3-one);

L. boldione (androsta-1,4-diene-3,17-dione);

M. 6-bromo-androsta-1,4-diene-3,17-dione;

N. 6-bromo-androstan-3,17-dione;

O. calusterone (7[BETA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one);

P. 4-chloro-17[ALPHA]-methyl-androsta-1,4-diene-3,17[BETA]-diol;

Q. 4-chloro-17[ALPHA]-methyl-androst-4-ene-3[BETA],17[BETA]-diol;

R. 4-chloro-17[ALPHA]-methyl-17[BETA]-hydroxy-androst-4-en-3-one;

S. 4-chloro-17[ALPHA]-methyl-17[BETA]-hydroxy-androst-4-ene-3,11-dione;

T. clostebol (4-chloro-17[BETA]-hydroxy-androst-4-en-3-one);

U. dehydrochloromethyltestosterone (4-chloro-17[BETA]-hydroxy-17[ALPHA]-methyl-androst-1,4-dien-3-one);

V. desoxymethyltestosterone (17[ALPHA]-methyl-5[ALPHA]-androst-2-en-17[BETA]-ol) (a.k.a. "madol");

W. 4-dihydrotestosterone (17[BETA]-hydroxy-androstan-3-one);

X. [DELTA]1-dihydrotestosterone (a.k.a. "1-testosterone") (17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one);

Y. 3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androstane;

Z. 3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androstane;

AA. 2[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxy-5[BETA]-androstan-3-one;

BB. drostanolone (17[BETA]-hydroxy-2[ALPHA]-methyl-5[ALPHA]-androstan-3-one);

CC. 2[ALPHA],3[ALPHA]-epithio-17[ALPHA]-methyl-5[ALPHA]-androstan-17[BETA]-ol;

DD. estra-4,9,11-triene-3,17-dione;

EE. 13[BETA]-ethyl-17[BETA]-hydroxygon-4-en-3-one;

FF. ethylestrenol (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-ene);

GG. fluoxymesterone (9-fluoro-17[ALPHA]-methyl-11[BETA],17[BETA]-dihydroxyandrost-4-en-3-one);

HH. formebolone (2-formyl-17[ALPHA]-methyl-11[ALPHA],17[BETA]-dihydroxyandrost-1,4-dien-3-one);

II. furazabol (17[ALPHA]-methyl-17[BETA]-hydroxyandrostano[2,3-c]furazan);

JJ. [3,2-c]furazan-5[ALPHA]-androstan-17[BETA]-ol;

KK. 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;

LL. 4-hydroxy-19-nortestosterone (4,17[BETA]-dihydroxy-estr-4-en-3-one);

MM. 4-hydroxy-androst-4-ene-3,17-dione;

NN. 17[BETA]-hydroxy-androstano[2,3-d]isoxazole;

OO. 17[BETA]-hydroxy-androstano[3,2-c]isoxazole;

PP. 3[BETA]-hydroxy-estra-4,9,11-trien-17-one;

QQ. 4-hydroxytestosterone (4,17[BETA]-dihydroxy-androst-4-en-3-one);

RR. mestanolone (17[ALPHA]-methyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);

SS. mesterolone (1[ALPHA]-methyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);

TT. methandienone (17[ALPHA]-methyl-17[BETA]-hydroxyandrost-1,4-dien-3-one);

UU. methandriol (17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-5-ene);

VV. methasterone (2[ALPHA],17[ALPHA]-dimethyl-5[ALPHA]-androstan-17[BETA]-ol-3-one or 2[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);

WW. methenolone (1-methyl-17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one);

XX. 17[ALPHA]-methyl-androsta-1,4-diene-3,17[BETA]-diol;

YY. 17[ALPHA]-methyl-5[ALPHA]-androstan-17[BETA]-ol;

ZZ. 17[ALPHA]-methyl-androstan-3-hydroxyimine-17[BETA]-ol;

AAA. 6[ALPHA]-methyl-androst-4-ene-3,17-dione;

BBB. 17[ALPHA]-methyl-androst-2-ene-3,17[BETA]-diol;

CCC. 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androstane;

DDD. 17[ALPHA]-methyl-3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androstane;

EEE. 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-4-ene;

FFF. 17[ALPHA]-methyl-4-hydroxynandrolone (17[ALPHA]-methyl-4-hydroxy-17[BETA]-hydroxyestr-4-en-3-one);

GGG. methyldienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9(10)-dien-3-one);

HHH. 17[ALPHA]-methyl-[DELTA]1-dihydrotestosterone (17[BETA]-hy-droxy-17[ALPHA]-methyl-5[ALPHA]-androst-1-en-3-one) (a.k.a. "17-[ALPHA]-meth-yl-1-testosterone");

III. methyltestosterone (17[ALPHA]-methyl-17[BETA]-hydroxyan-drost-4-en-3-one);

JJJ. methyltrienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9,11-trien-3-one);

KK. mibolerone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyestr-4-en-3-one);

LLL. nandrolone (17[BETA]-hydroxyestr-4-en-3-one);

MMM. 19-nor-4-androstenediol (3[BETA],17[BETA]-dihydroxyestr-4-ene);

NNN. 19-nor-4-androstenediol (3[ALPHA],17[BETA]-dihydroxyestr-4-ene);

OOO. 19-nor-5-androstenediol (3[BETA],17[BETA]-dihydroxyestr-5-ene);

PPP. 19-nor-5-androstenediol (3[ALPHA],17[BETA]-dihydroxyestr-5-ene);

QQQ. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);

RRR. 19-nor-4-androstenedione (estr-4-en-3,17-dione);

SSS. 19-nor-5-androstenedione (estr-5-en-3,17-dione);

TTT. norbolethone (13[BETA],17[ALPHA]-diethyl-17[BETA]-hydroxygon-4-en-3-one);

UUU. norclostebol (4-chloro-17[BETA]-hydroxyestr-4-en-3-one);

VVV. norethandrolone (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-en-3-one);

WWW. normethandrolone (17[ALPHA]-methyl-17[BETA]-hydroxyestr-4-en-3-one);

XXX. oxandrolone (17[ALPHA]-methyl-17[BETA]-hydroxy-2-oxa-5[ALPHA]-androstan-3-one);

YYY. oxymesterone (17[ALPHA]-methyl-4,17[BETA]-dihydroxyandrost-4-en-3-one);

ZZZ. oxymetholone (17[ALPHA]-methyl-2-hydroxymethylene-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);

AAAA. prostanozol (17[BETA]-hydroxy-5[ALPHA]-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5[ALPHA]-androstan-17[BETA]-ol);

BBBB. [3,2-c]pyrazole-androst-4-en-17[BETA]-ol;

CCCC. stanozolol (17[ALPHA]-methyl-17[BETA]-hydroxy-5 -androst-2-eno[3,2-c]-pyrazole);

DDDD. stenbolone (17[BETA]-hydroxy-2-methyl-5[ALPHA]-androst-1-en-3-one);

EEEE. testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);

FFFF. testosterone (17[BETA]-hydroxyandrost-4-en-3-one);

GGGG. tetrahydrogestrinone (13[BETA],17[ALPHA]-diethyl-17[BETA]-hydroxygon-4,9,11-trien-3-one); and

HHHH. trenbolone (17[BETA]-hydroxyestr-4,9,11-trien-3-one).

7. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369

(Some other names for dronabinol: (6[ALPHA]Rtrans)- 6a,7,8,10[ALPHA]-tetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

(D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

1. Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

A. Not more than one milligram (1 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit	9167
B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)	9278
C. 2-1-(3-methoxyphenyl) cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)	9752
D. Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
(I) Not more than two hundred milligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
(II) Not more than one hundred milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or
(III) Not more than one hundred milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

2. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Alfaxalone	2731
B. Alprazolam	2882
C. Barbital	2145
D. Brexanolone	2400
E. Bromazepam	2748
F. Camazepam	2749
G. Carisoprodol	8192
H. Chloral betaine	2460
I. Chloral hydrate	2465
J. Chlordiazepoxide	2744
K. Clobazam	2751
L. Clonazepam	2737
M. Clorazepate	2768
N. Clotiazepam	2752
O. Cloxazolam	2753
P. Daridorexant	2410
Q. Delorazepam	2754
R. Diazepam	2765
S. Dichloralphenazone	2467
T. Estazolam	2756
U. Ethchlorvynol	2540
V. Ethinamate	2545
W. Ethyl loflazepate	2758
X. Fludiazepam	2759
Y. Flunitrazepam	2763
Z. Flurazepam	2767
AA. Fospropofol	2138
BB. Halazepam	2762
CC. Haloxazolam	2771
DD. Ketazolam	2772
EE. Lemborexant	2245
FF. Loprazolam	2773
GG. Lorazepam	2885
HH. Lormetazepam	2774
II. Mebutamate	2800
JJ. Medazepam	2836
KK. Meprobamate	2820
LL. Methohexital	2264
MM. Methylphenobarbital (Mephobarbital)	2250
NN. Midazolam	2884
OO. Nimetazepam	2837
PP. Nitrazepam	2834
QQ. Nordiazepam	2838
RR. Oxazepam	2835
SS. Oxazolam	2839
TT. Paraldehyde	2585
UU. Petrichloral	2591
VV. Phenobarbital	2285
WW. Pinazepam	2883
XX. Prazepam	2764
YY. Quazepam	2881
ZZ. Remimazolam	2846
AAA. Suvorexant	2223
BBB. Temazepam	2925
CCC. Tetrazepam	2886
DDD. Triazolam	2887
EEE. Zaleplon	2781
FFF. Zolpidem	2783
GGG. Zopiclone	2784

3. Lorcaserin. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

A. Lorcaserin

1625

4. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

A. Cathine ((+)-norpseudoephedrine)	1230
B. Diethylpropion	1610
C. Fencamfamin	1760
D. Fenproporex	1575
E. Mazindol	1605
F. Mefenorex	1580
G. Modafinil	1680
H. Pemoline (including organometallic complexes and chelates thereof)	1530
I. Phentermine	1640
J. Pipradrol	1750
K. Serdexmethylphenidate	1729
L. Sibutramine	1675
M. Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))	1650
N. SPA (-)-1-dimethylamino-1,2-diphenylethane	1635

5. Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

A. Pentazocine	9709
B. Butorphanol (including its optical isomers)	9720
C. Eluxadoline (5-[[[(2S)-2-amino-3-[4- aminocarbonyl)-2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl-1 H-imidazol-2-yl) ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers	9725

6. Ephedrine. Any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:

A. Ephedrine or its salts, optical isomers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.

(E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.

1. Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

A. Not more than two hundred milligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

B. Not more than one hundred milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

C. Not more than one hundred milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

D. Not more than two and five-tenths milligrams (2.5 mg) of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

E. Not more than one hundred milligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

F. Not more than five-tenths milligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit.

2. Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:

A. Pyrovalerone

1485

3. Any compound, mixture, or preparation containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starch-based solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:

A. Drug preparations in liquid form; and

B. Drug preparations that require a prescription in order to be dispensed.

4. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

A. Ezogabine	2779
B. Ganaxolone (3a-hydroxy-3[BETA]methyl-5[ALPHA]-pregnan-20-one)	2401
C. Lacosamide	2746
D. Pregabalin	2782
E. Brivaracetam ((25)-2-butanamide) (also referred to as BRV; UCB-34714; Briviact)	2710
F. Lasmiditan	2790
G. Cenobamate (carbamate; 2Htetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol2-yl)ethyl ester)	2720

(2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo.

Excluded Nonnarcotic Products

Company	Trade Name	NDC Code	Form	Controlled Substance	mg or mg/mL
Bioline Laboratories	Theophed	00719-1945	TB	Phenobarbital	8.00
Aphena Pharma Solutions-New York, LLC	Nasal decongestant/ inhaler/vapor	Levometamfetamine (l-desoxyephedrine)	50.00
Goldline Laboratories	Guiaphed Elixir	00182-1377	EL	Phenobarbital	4.00
Goldline Laboratories	Tedrigen Tablets	00182-0134	TB	Phenobarbital	8.00
Hawthorne Products, Inc.	Choate's Leg Freeze	LQ	Chloral hydrate	246.67
Parke-Davis & Co.	Tedral	00071-0230	TB	Phenobarbital	8.00
Parke-Davis & Co.	Tedral Elixir	00071-0242	EX	Phenobarbital	40.00
Parke-Davis & Co.	Tedral S.A.	00071-0231	TB	Phenobarbital	8.00
Parke-Davis & Co.	Tedral Suspension	00071-0237	SU	Phenobarbital	80.00
Parmed Pharmacy	Asma-Ese	00349-2018	TB	Phenobarbital	8.10
Rondex Labs	Azma-Aids	00367-3153	TB	Phenobarbital	8.00
Smith Kline Consumer	Benzedrex	49692-0928	IN	Propylhexedrine	250.00
Sterling Drug, Inc.	Bronkolixir	00057-1004	EL	Phenobarbital	0.80
Sterling Drug, Inc.	Bronkotabs	00057-1005	TB	Phenobarbital	8.00
Vicks Chemical Co.	Vicks Inhaler	23900-0010	IN	I-Desoxyephedrine	113.00
White Hall Labs	Primatene (P-tablets)	00573-2940	TB	Phenobarbital	8.00

19 CSR 30-1.002

AUTHORITY: sections 195.015 and 195.195, RSMo 2000.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003.

Amended by Missouri Register April 3, 2017/Volume 42, Number 07, effective 5/31/2017

Amended by Missouri Register March 15, 2019/Volume 44, Number 6, effective 4/30/2019

Amended by Missouri Register March 15, 2021/Volume 46, Number 06, effective 4/30/2021

Amended by Missouri Register November 1, 2021/Volume 46, Number 21, effective 10/13/2021

Amended by Missouri Register February 15, 2022/Volume 47, Number 4, effective 3/31/2022

Amended by Missouri Register February 1, 2023/Volume 48, Number 3, effective 3/31/2023

Amended by Missouri Register November 1, 2023/volume 48, Number 21, effective 10/10/2023, exp. 4/6/2024 (Emergency)

Amended by Missouri Register February 15, 2024/volume 49, Number 04, effective 3/31/2024.

*Original authority: 115.015, RSMo 1971, amended 1989 and 195.195, RSMo 1957, amended 1971, 1989, 1993.